Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Marc Bach-Griera"'
Autor:
Marc Bach-Griera, Víctor Campo-Pérez, Sandra Barbosa, Sara Traserra, Sandra Guallar-Garrido, Laura Moya-Andérico, Paula Herrero-Abadía, Marina Luquin, Rosa Maria Rabanal, Eduard Torrents, Esther Julián
Publikováno v:
Vaccines, Vol 8, Iss 2, p 198 (2020)
Intravesical Mycobacterium bovis Bacillus Calmette–Guérin (BCG) immunotherapy remains the gold-standard treatment for non-muscle-invasive bladder cancer patients, even though half of the patients develop adverse events to this therapy. On explorin
Externí odkaz:
https://doaj.org/article/faaa4869d01143d39eb9b58ce13d07a3
Autor:
Laura Moya-Andérico, Víctor Campo-Pérez, Eduard Torrents, Sara Traserra, Sandra Barbosa, Sandra Guallar-Garrido, Esther Julián, Paula Herrero-Abadía, Marina Luquin, R.M. Rabanal, Marc Bach-Griera
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Vaccines
Volume 8
Issue 2
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Vaccines, Vol 8, Iss 198, p 198 (2020)
Universidad de Barcelona
Vaccines
Volume 8
Issue 2
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Vaccines, Vol 8, Iss 198, p 198 (2020)
Intravesical Mycobacterium bovis Bacillus Calmette&ndash
Gué
rin (BCG) immunotherapy remains the gold-standard treatment for non-muscle-invasive bladder cancer patients, even though half of the patients develop adverse events to this
Gué
rin (BCG) immunotherapy remains the gold-standard treatment for non-muscle-invasive bladder cancer patients, even though half of the patients develop adverse events to this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f6f7639254f77d4a3e3036c60263b03
http://hdl.handle.net/2445/174370
http://hdl.handle.net/2445/174370
